View Mobile Friendly Conference List »

Setting new standards in information exchange for the pharmaceutical and biotech industry


A Big Thank You to the Entire DPharm US Community & Next Dates

  • September 21, 2015

  • We would like to thank the entire DPharm US community for an intense and productive event. As one attendee put it,
    the passion for innovation was palpable throughout the entire conference as well as learning more about innovations that are currently being implemented.”

    Opera Singer and Recipient of Two Double Lung Transplants, Charity Tillmann-Dick Performing at Dpharm

    It is an ambitious endeavor to present so many examples of innovation to advance clinical trials for the benefit of patients. (A 2nd track is in order for 2016!) We could not have opened the program in a more memorable way with the magnificent story of the greatest patient voice of all, opera singer and recipient of two double lung transplants, Charity Tillmann-Dick.

    This followed with Life Science Leader Chief, Rob Wright in a Keynote Panel on Culture for Innovation. DPharm featured everything from the latest technologies, to futuristic thoughts, FDA insights, more patient voices and examples of collaborations.
    For details on all the sessions, click here. The 2016 program dates are September 20-21 at the Fairmont Copley Hotel, Boston.  The Mobile in Clinical Trials program will take place on September 19th. DPharm Europe is scheduled for February 9-10 in London.

    Kudos to all involved! If interested in presenting innovations with real outcomes at either the 2016 DPharm US or DPharm Europe , let us know at

    The seven top comments from attendees on what they got at Dpharm 2015:

    1.  Immersed in current state of play and ongoing developments
    2.  An introduction of ways to discuss process impact of disruptive innovations
    3.  Valuable perspectives
    4.  Connecting and engaging with other leaders of innovation
    5.  How other companies are innovating
    6.  Opportunities to learn more about our industry’s efforts to become more patient-centric utilizing innovative new opportunities to collaborate
    7.  Outstanding networking opportunities with people who really care about making a difference for patients in clinical trials